The pharmaceutical company Amgen is suing the Colorado Prescription Drug Affordability Board after the price of one of its ...

Pharmaceutical company Amgen sued the Colorado Prescription Drug Affordability Board over a price cap the board placed on Enbrel.

Colorado finalized the nation’s first prescription drug price cap Oct. 3, establishing an upper payment limit for Enbrel, an autoimmune medication, through the state’s prescription drug affordability ...

Colorado regulators have approved a dramatic price cap on one of the nation’s best-selling drugs, cutting its price to less than one-third of its previous level, in a novel attempt by a state to ...

The new lawsuit argues that the board’s action conflicted with federal patent laws by not allowing the company to charge as much as it wants.

Amgen reported stronger-than-expected quarterly financial results, raising its full-year forecast. The biotech company's 12% ...

Inside Providence plan 340B rebate disruption details the system’s financial and operational readiness for the new federal rebate pilot program.